2006-5-1
‰ŧŠw‰ïŽÐ‚ĖŠCŠOioˆę—— ‘æˆęŽO‹Ī ’†‘


’†‘Žq‰ïŽÐ‚ĖŽ–‹Æ“Š‡‹y‚Ņ“ŠŽ‘

ŽÐ–ž ‘æˆęŽO‹Īi’†‘j“ŠŽ‘—LŒĀŒöŽi@@@@@@@@
ęŠ ãŠCŽs
Š”Žå ‘æˆęŽO‹Ī 100%
Ý—§ 2011/11/8
”\—Í @
”õl @


ˆã–ō•i‚ĖŠJ”­Eŧ‘ĒE”Ė”„

ŽÐ–ž ‘æˆęŽO‹Īŧ–ōi–k‹žj—LŒĀŒöŽi
  ‹ŒĖ@
Daiichi Pharmaceutical (Beijing) Co., Ltd.
ęŠ –k‹žŽs
Š”Žå ‘æˆęŽO‹Ī 100%

“–‰‚Í–k‹žŽsˆã–ōW’c—LŒĀÓ”CŒöŽi‚Æ‚ĖJV
Ý—§ 1998/5
”\—Í @
”õl Žå—vŧ•iF‡ŽR‹ÛÜƒNƒ‰ƒrƒbƒgA‡ŽR‹ÛÜƒ^ƒŠƒrƒbƒh

@

ˆã–ō•i‚ĖŠJ”­Eŧ‘ĒE”Ė”„

ŽÐ–ž ‘æˆęŽO‹Īŧ–ōiãŠCj—LŒĀŒöŽi
@@‹ŒĖ@
ãŠCŽO‹Īŧ–ō—LŒĀŒöŽi
ęŠ ãŠC
Š”Žå ‘æˆęŽO‹Ī 100%
Ý—§ 1999/11
”\—Í @
”õl Žå—vŧ•iF@
 ‚ŒŒˆģĮŽĄ—Í܃Iƒ‹ƒƒeƒbƒNA‚ƒRƒŒƒXƒeƒ[ƒ‹ŒŒĮŽĄ—Í܃ƒoƒƒ`ƒ“A
 Á‰Š’Á’ɉð”MÜƒƒLƒ\ƒjƒ“A’ÁŠP‹Žá‚ÜƒAƒXƒƒgƒ“ARķ•ĻŽŋŧÜƒZƒtƒƒ^ƒ]ƒ“A
 Rķ•ĻŽŋŧÜƒJƒ‹ƒxƒjƒ“